- | CCO
Registration and Breakfast Coffee Talk with Key Opinion Leaders In-person learners are invited to start off the morning with key opinion leaders as well as other colleagues to enjoy coffee and informal discussions about a hot topic related to mood disorders
- 2024 Myeloma Treatment Algorithm
Newly Diagnosed Active Multiple Myeloma: Special Settings *Consider salvage ASCT in patients eligible for ASCT who have not had transplant before; consider second ASCT if eligible and had >36-month response duration with maintenance to first ASCT
- Complexities in HER2+ MBC | CCO - clinicaloptions. com
As a nationally recognized provider of continuing education for healthcare professionals, CCO develops, delivers, and evaluates a broad range of accredited, cutting-edge CME and CE opportunities
- Schizophrenia Treatment | CCO
As a nationally recognized provider of continuing education for healthcare professionals, CCO develops, delivers, and evaluates a broad range of accredited, cutting-edge CME and CE opportunities
- REPRIEVE Mexico | CCO
As a nationally recognized provider of continuing education for healthcare professionals, CCO develops, delivers, and evaluates a broad range of accredited, cutting-edge CME and CE opportunities
- Asparaginase as the Cornerstone for ALL Chemotherapy | CCO
Certified on-demand webcast where an expert provides an overview of and rationale for asparaginase in the treatment of acute lymphoblastic leukemia, summarizes treatment outcomes in pediatric patients and adolescents and young adults, and compares pediatric and adult regimens
- Acalabrutinib in CLL | CCO
As a nationally recognized provider of continuing education for healthcare professionals, CCO develops, delivers, and evaluates a broad range of accredited, cutting-edge CME and CE opportunities
- Treating Relapsed CLL | CCO
In this activity, experts answer key questions about the treatment of R R CLL and provide insightful information that HCPs can apply in the clinic
|